[Tracheomalacia (TM) or bronchomalacia (BM) in children: conservative or invasive therapy].
Tracheomalacia (TM) or bronchomalacia (BM) refers to softness or weakness of the trachea or the bronchi. Its management is not evidenced-based. Conservative therapy is preferred in milder cases, since the outcome is usually favourable within the first 2 years of life. The clinical utility of non-specific treatments (anti-inflammatory agents, bronchodilators, antibiotics, physiotherapy) has not been proven by clinical trials. Treatment of symptomatic cases should be discussed on an individual basis. Airway surgery should be avoided, and non-invasive ventilation may be proposed as a temporary measure. In case of very severe cases, aortopexy, trachostomy or stent placement are the preferred treatments. Regular respiratory monitoring until remission is mandatory.
Fayon
M
M
Service de pneumologie pédiatrique, hôpital d'Enfants-Pellegrin, place Amélie-Raba-Léon, 33076 Bordeaux, France. michael.fayon@chu-bordeaux.fr
Donato
L
L
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001013:Aorta, Thoracic / Q000601:surgery; D001993:Bronchodilator Agents / Q000008:administration & dosage; D055091:Bronchomalacia / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D026741:Physical Therapy Modalities; D011379:Prognosis; D015607:Stents; D013537:Sutures; D055090:Tracheomalacia / Q000175:diagnosis / Q000628:therapy*; D014139:Tracheostomy
D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001993:Bronchodilator Agents